Stocks and Investing
Stocks and Investing
Fri, May 31, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Yigal Nochomovitz Downgraded (CALT) to Hold and Held Target at $39 on, May 31st, 2024
Yigal Nochomovitz of Citigroup, Downgraded "Calliditas Therapeutics AB (publ)" (CALT) to Hold and Held Target at $39 on, May 31st, 2024.
Yigal has made no other calls on CALT in the last 4 months.
There are 3 other peers that have a rating on CALT. Out of the 3 peers that are also analyzing CALT, all agree with Yigal's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Annabel Samimy of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Tuesday, May 28th, 2024
- Arthur He of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Held Target at $39 on, Tuesday, May 28th, 2024
- Maury Raycroft of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $39 on, Tuesday, May 28th, 2024
Contributing Sources